TIDMRTW

RNS Number : 9746X

RTW Venture Fund Limited

02 May 2023

LEI: 549300Q7EXQQH6KF7Z84

2 May 2023

RTW Venture Fund Limited

Annual Financial Report

Year ended 31 December 2022

A tagged copy of the above document was submitted to the National Storage Mechanism on 28 April 2023 and is

available for inspection at    https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For Further Information:

 
 RTW Investments, LP                         +44 (0)20 7959 6361 
 Woody Stileman, Managing Director 
  Krisha McCune, Director, Client Service 
 
 Buchanan                                    +44 (0)20 7466 5107 
 Charles Ryland 
 Henry Wilson 
 George Beale 
 
 Numis                                       +44 (0)20 7260 1000 
 Freddie Barnfield 
 Nathan Brown 
 Euan Brown 
 
 BofA Securities                             +44 (0) 20 7628 1000 
 Edward Peel 
 Kieran Millar

About RTW Venture Fund Limited:

RTW Venture Fund Limited (LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.

RTW Venture Fund Limited is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.

Visit the RTW website at www.rtwfunds.com for more information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACSSSDFFFEDSEII

(END) Dow Jones Newswires

May 02, 2023 02:00 ET (06:00 GMT)

Rtw Biotech Opportunities (LSE:RTWG)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025 Click aqui para mais gráficos Rtw Biotech Opportunities.
Rtw Biotech Opportunities (LSE:RTWG)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025 Click aqui para mais gráficos Rtw Biotech Opportunities.